Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis

被引:310
作者
Caussy, Cyrielle [1 ,2 ]
Alquiraish, Mosab H. [1 ]
Nguyen, Phirum [1 ]
Hernandez, Carolyn [1 ]
Cepin, Sandra [1 ]
Fortney, Lynda E. [1 ]
Ajmera, Veeral [1 ,3 ]
Bettencourt, Ricki [1 ]
Collier, Summer [1 ]
Hooker, Jonathan [4 ]
Sy, Ethan [4 ]
Rizo, Emily [1 ]
Richards, Lisa [1 ]
Sirlin, Claude B. [4 ]
Loomba, Rohit [1 ,3 ,5 ]
机构
[1] Univ Calif San Diego, Dept Med, NAFLD Res Ctr, La Jolla, CA 92093 USA
[2] Univ Lyon 1, Hosp Civils Lyon, Lyon, France
[3] Dept Med, Div Gastroenterol, La Jolla, CA USA
[4] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, La Jolla, CA 92093 USA
[5] Univ Calif San Diego, Div Epidemiol, Dept Family & Prevent Med, La Jolla, CA 92093 USA
关键词
NONALCOHOLIC FATTY LIVER; MAGNETIC-RESONANCE ELASTOGRAPHY; NATURAL-HISTORY; QUANTITATIVE ASSESSMENT; TRANSIENT ELASTOGRAPHY; NONINVASIVE EVALUATION; XL PROBE; DISEASE; FIBROSIS; STEATOHEPATITIS;
D O I
10.1002/hep.29639
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
The optimal threshold of controlled attenuation parameter (CAP) for the detection of hepatic steatosis using both M and XL probe is unknown in nonalcoholic fatty liver disease (NAFLD). Magnetic resonance imaging proton density fat fraction (MRI-PDFF) is an accurate and precise method of detecting the presence of hepatic steatosis that is superior to CAP. Thus, the aim of this study was to evaluate the diagnostic accuracy and optimal threshold of CAP for the detection of hepatic steatosis as defined by MRI-PDFF5%. This prospective cross-sectional study included 119 adults (59% women) with and without NAFLD who underwent MRI-PDFF and CAP using either M or XL probe when indicated within a 6-month period at the NAFLD Research Center, University of California, San Diego. The mean (+/- standard deviation) age and body mass index were 52.4 (+/- 15.2) years and 29.9 (+/- 5.5) kg/m(2), respectively. The prevalence of NAFLD (MRI-PDFF5%) and MRI-PDFF10% was 70.6% and 47.1%, respectively. The area under the receiver operating characteristic (AUROC) of CAP for the detection of MRI-PDFF5% was 0.80 (95% confidence interval [CI], 0.70-0.90) at the cut-point of 288 dB/m and of MRI-PDFF10% was 0.87 (95% CI, 0.80-0.94) at the cut-point of 306 dB/m. When stratified by the interquartile range (IQR) of CAP, we observed that an IQR below the median (30 dB/m) had a robust AUROC compared with an IQR above the median (0.92 [95% CI, 0.85-1.00] versus 0.70 [95% CI, 0.56-0.85]; P=0.0117), and these differences were statistically and clinically significant. Conclusion: The cut-point of CAP for presence of hepatic steatosis (MRI-PDFF5%) was 288 dB/m. The diagnostic accuracy of CAP for the detection of hepatic steatosis is more reliable when the IQR of CAP is <30 dB/m. These data have implications for the clinical use of CAP in the assessment of NAFLD. (Hepatology 2018;67:1348-1359)
引用
收藏
页码:1348 / 1359
页数:12
相关论文
共 53 条
[1]
Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis [J].
Asrani, Sumeet K. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (12) :2190-2204
[2]
Current concepts: Liver biopsy. [J].
Bravo, AA ;
Sheth, SG ;
Chopra, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :495-500
[3]
Non-invasive evaluation of liver fibrosis using transient elastography [J].
Castera, Laurent ;
Forns, Xavier ;
Alberti, Alfredo .
JOURNAL OF HEPATOLOGY, 2008, 48 (05) :835-847
[4]
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis [J].
Caussy, Cyrielle ;
Soni, Meera ;
Cui, Jeffrey ;
Bettencourt, Ricki ;
Schork, Nicholas ;
Chen, Chi-Hua ;
Al Ikhwan, Mahdi ;
Bassirian, Shirin ;
Cepin, Sandra ;
Gonzalez, Monica P. ;
Mendler, Michel ;
Kono, Yuko ;
Vodkin, Irine ;
Mekeel, Kristin ;
Haldorson, Jeffrey ;
Hemming, Alan ;
Andrews, Barbara ;
Salotti, Joanie ;
Richards, Lisa ;
Brenner, David A. ;
Sirlin, Claude B. ;
Loomba, Rohit .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07) :2697-2704
[5]
Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population [J].
Chan, Wah-Kheong ;
Mustapha, Nik Raihan Nik ;
Wong, Grace Lai-Hung ;
Wong, Vincent Wai-Sun ;
Mahadeva, Sanjiv .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (01) :76-85
[6]
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States [J].
Charlton, Michael R. ;
Burns, Justin M. ;
Pedersen, Rachel A. ;
Watt, Kymberly D. ;
Heimbach, Julie K. ;
Dierkhising, Ross A. .
GASTROENTEROLOGY, 2011, 141 (04) :1249-1253
[7]
Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population [J].
Chon, Young Eun ;
Jung, Kyu Sik ;
Kim, Seung Up ;
Park, Jun Yong ;
Park, Young Nyun ;
Kim, Do Young ;
Ahn, Sang Hoon ;
Chon, Chae Yoon ;
Lee, Hye Won ;
Park, Yehyun ;
Han, Kwang-Hyub .
LIVER INTERNATIONAL, 2014, 34 (01) :102-109
[8]
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study [J].
Cui, Jeffrey ;
Chen, Chi-Hua ;
Lo, Min-Tzu ;
Schork, Nicholas ;
Bettencourt, Ricki ;
Gonzalez, Monica P. ;
Bhatt, Archana ;
Hooker, Jonathan ;
Shaffer, Katherine ;
Nelson, Karen E. ;
Long, Michelle T. ;
Brenner, David A. ;
Sirlin, Claude B. ;
Loomba, Rohit .
HEPATOLOGY, 2016, 64 (05) :1547-1558
[9]
Controlled Attenuation Parameter (CAP) with the XL Probe of the FibroscanA®: A Comparative Study with the M Probe and Liver Biopsy [J].
de Ledinghen, Victor ;
Hiriart, Jean-Baptiste ;
Vergniol, Julien ;
Merrouche, Wassil ;
Bedossa, Pierre ;
Paradis, Valerie .
DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (09) :2569-2577
[10]
Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE [J].
Doycheva, I. ;
Cui, J. ;
Nguyen, P. ;
Costa, E. A. ;
Hooker, J. ;
Hofflich, H. ;
Bettencourt, R. ;
Brouha, S. ;
Sirlin, C. B. ;
Loomba, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) :83-95